Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with ¹⁵O-Gas PET and Singular Value Decomposition

References

1. 1.↵
   2. Ostergaard L,
   3. Weisskoff RM,
   4. Chesler DA, et al

   . High-resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–75 doi:10.1002/mrm.1910360510 pmid:8916022

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Ostergaard LW,
   3. Chesler DA,
   4. Gyldensted C, et al

   . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36 doi:10.1002/mrm.1910360511 pmid:8916023

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Wintermark M,
   3. Sesay M,
   4. Barbier E, et al

   . Comparative overview of brain perfusion imaging techniques. Stroke 2005;36:e83–99 doi:10.1161/01.STR.0000177884.72657.8b pmid:16100027

   Abstract/FREE Full Text
4. 4.↵
   2. Lansberg MG,
   3. Lee J,
   4. Christensen S, et al

   . RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke 2011;42:1608–14 doi:10.1161/STROKEAHA.110.609008 pmid:21493916

   Abstract/FREE Full Text
5. 5.↵
   2. Tanaka Y,
   3. Nariai T,
   4. Nagaoka T, et al

   . Quantitative evaluation of cerebral hemodynamics in patients with Moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging: comparison with positron emission tomography. J Cereb Blood Flow Metab 2006;26:291–300 doi:10.1038/sj.jcbfm.9600187 pmid:16049427

   CrossRefPubMed
6. 6.↵
   2. Ibaraki M,
   3. Shimosegawa E,
   4. Toyoshima H, et al

   . Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: comparison with 15O-PET. Magn Reson Med Sci 2005;4:27–34 doi:10.2463/mrms.4.27 pmid:16127251

   CrossRefPubMed
7. 7.↵
   2. Lin W,
   3. Celik A,
   4. Derdeyn C, et al

   . Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging 2001;14:659–67 doi:10.1002/jmri.10021 pmid:11747021

   CrossRefPubMed
8. 8.↵
   2. Mukherjee P,
   3. Kang HC,
   4. Videen TO, et al

   . Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. AJNR Am J Neuroradiol 2003;24:862–71 pmid:12748086

   Abstract/FREE Full Text
9. 9.↵
   2. Ostergaard L,
   3. Johannsen P,
   4. Host-Poulsen P, et al

   . Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935–40 doi:10.1097/00004647-199809000-00002 pmid:9740096

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Vakil P,
    3. Lee JJ,
    4. Mouannes-Srour JJ, et al

    . Cerebrovascular occlusive disease: quantitative cerebral blood flow using dynamic susceptibility contrast MR imaging correlates with quantitative H2[15O] PET. Radiology 2013;266:879–86 doi:10.1148/radiol.12120756 pmid:23297337

    CrossRefPubMed
11. 11.↵
    2. Boutelier T,
    3. Kudo K,
    4. Pautot F, et al

    . Bayesian hemodynamic parameter estimation by bolus tracking perfusion weighted imaging. IEEE Trans Med Imaging 2012;31:1381–95 doi:10.1109/TMI.2012.2189890 pmid:22410325

    CrossRefPubMed
12. 12.↵
    2. Kudo K,
    3. Christensen S,
    4. Sasaki M, et al

    . Accuracy and reliability assessment of CT and MR perfusion analysis software using a digital phantom. Radiology 2013;267:201–11 doi:10.1148/radiol.12112618 pmid:23220899

    CrossRefPubMed
13. 13.↵
    2. Kudo K,
    3. Boutelier T,
    4. Pautot F, et al

    . Bayesian analysis of perfusion-weighted imaging to predict infarct volume: comparison with singular value decomposition. Magn Reson Med Sci 2014;13:45–50 doi:10.2463/mrms.2013-0085 pmid:24492744

    CrossRefPubMed
14. 14.↵
    2. Nicoli F,
    3. Scalzo F,
    4. Saver JL, et al

    . The combination of baseline magnetic resonance perfusion-weighted imaging-derived tissue volume with severely prolonged arterial-tissue delay and diffusion-weighted imaging lesion volume is predictive of MCA-M1 recanalization in patients treated with endovascular thrombectomy. Neuroradiology 2014;56:117–27 doi:10.1007/s00234-013-1310-2 pmid:24337610

    CrossRefPubMed
15. 15.↵
    2. Nael K,
    3. Mossadeghi B,
    4. Boutelier T, et al

    . Bayesian estimation of cerebral perfusion using reduced-contrast-dose dynamic susceptibility contrast perfusion at 3T. AJNR Am J Neuroradiol 2015;36:710–18 doi:10.3174/ajnr.A4184 pmid:25430859

    Abstract/FREE Full Text
16. 16.↵
    2. Hansen MB,
    3. Tietze A,
    4. Kalpathy-Cramer J, et al

    . Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI. J Magn Reson Imaging 2017;46:537–49 doi:10.1002/jmri.25549 pmid:27902858

    CrossRefPubMed
17. 17.↵
    Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 2012;52:245–66 doi:10.2176/nmc.52.245 pmid:22870528

    CrossRefPubMed
18. 18.↵
    2. Wu O,
    3. Ostergaard L,
    4. Weisskoff RM, et al

    . Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164–74 doi:10.1002/mrm.10522 pmid:12815691

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Sasaki M,
    3. Kudo K,
    4. Boutelier T, et al

    . Assessment of the accuracy of a Bayesian estimation algorithm for perfusion CT by using a digital phantom. Neuroradiology 2013;55:1197–1203 doi:10.1007/s00234-013-1237-7 pmid:23852431

    CrossRefPubMed
20. 20.↵
    2. Mouridsen K,
    3. Christensen S,
    4. Gyldensted L, et al

    . Automatic selection of arterial input function using cluster analysis. Magn Reson Med 2006;55:524–31 doi:10.1002/mrm.20759 pmid:16453314

    CrossRefPubMed
21. 21.↵
    2. Bettinardi V,
    3. Presotto L,
    4. Rapisarda E, et al

    . Physical performance of the new hybrid PETCT Discovery-690. Med Phys 2011;38:5394–5411 doi:10.1118/1.3635220 pmid:21992359

    CrossRefPubMed
22. 22.↵
    2. Shidahara M,
    3. Watabe H,
    4. Kim KM, et al

    . Optimal scan time of oxygen-15-labeled gas inhalation autoradiographic method for measurement of cerebral oxygen extraction fraction and cerebral oxygen metabolic rate. Ann Nucl Med 2008;22:667–75 doi:10.1007/s12149-008-0157-9 pmid:18982469

    CrossRefPubMed
23. 23.↵
    2. Kudomi N,
    3. Choi E,
    4. Yamamoto S, et al

    . Development of a GSO detector assembly for a continuous blood sampling system. IEEE Trans Nucl Sci 2003;50:70–73 doi:10.1109/TNS.2002.807869

    CrossRef
24. 24.
    2. Miwa K,
    3. Umeda T,
    4. Murata T, et al

    . Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging. Nucl Med Commun 2016;37:147–54 doi:10.1097/MNM.0000000000000403 pmid:26440565

    CrossRefPubMed
25. 25.↵
    2. Shidahara M,
    3. Watabe H,
    4. Kim KM, et al

    . Evaluation of a commercial PET tomograph-based system for the quantitative assessment of rCBF, rOEF and rCMRO2 by using sequential administration of 15O-labeled compounds. Ann Nucl Med 2002;16:317–27 doi:10.1007/BF02988616 pmid:12230091

    CrossRefPubMed
26. 26.↵
    2. Hara S,
    3. Tanaka Y,
    4. Ueda Y, et al

    . Noninvasive evaluation of CBF and perfusion delay of Moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: comparison with ¹⁵O-gas PET and DSC-MRI. AJNR Am J Neuroradiol 2017;38:696–702 doi:10.3174/ajnr.A5068 pmid:28209582

    Abstract/FREE Full Text
27. 27.↵
    2. Kimura H,
    3. Kado H,
    4. Koshimoto Y, et al

    . Multislice continuous arterial spin-labeled perfusion MRI in patients with chronic occlusive cerebrovascular disease: a correlative study with CO2 PET validation. J Magn Reson Imaging 2005;22:189–98 doi:10.1002/jmri.20382 pmid:16028241

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Grandin CB,
    3. Bol A,
    4. Smith AM, et al

    . Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans. Neuroimage 2005;26:525–35 doi:10.1016/j.neuroimage.2005.02.028 pmid:15907309

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Takasawa M,
    3. Jones PS,
    4. Guadagno JV, et al

    . How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008;39:870–77 doi:10.1161/STROKEAHA.107.500090 pmid:18258831

    Abstract/FREE Full Text
30. 30.↵
    2. Sakoh M,
    3. Rohl L,
    4. Gyldensted C, et al

    . Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: comparison with [(15)O]H(2)O positron emission tomography. Stroke 2000;31:1958–64 doi:10.1161/01.STR.31.8.1958 pmid:10926964

    Abstract/FREE Full Text
31. 31.↵
    2. Nariai T,
    3. Matsushima Y,
    4. Imae S, et al

    . Severe haemodynamic stress in selected subtypes of patients with Moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 2005;76:663–69 doi:10.1136/jnnp.2003.025049 pmid:15834024

    Abstract/FREE Full Text
32. 32.↵
    2. Hirai S,
    3. Inaji M,
    4. Tanaka Y, et al

    . Correlation between clinical presentations and hemodynamic parameters measured by dynamic susceptibility contrast magnetic resonance imaging in adult patients with Moyamoya disease. J Stroke Cerebrovasc Dis 2017;26:2814–20 doi:10.1016/j.jstrokecerebrovasdis.2017.06.057 pmid:28778721

    CrossRefPubMed
33. 33.↵
    2. Ishii Y,
    3. Nariai T,
    4. Tanaka Y, et al

    . Practical clinical use of dynamic susceptibility contrast magnetic resonance imaging for the surgical treatment of Moyamoya disease. Neurosurgery 2014;74:302–09 doi:10.1227/NEU.0000000000000266 pmid:24335813

    CrossRefPubMed
34. 34.↵
    2. Ishii Y,
    3. Tanaka Y,
    4. Momose T, et al

    . Chronologic evaluation of cerebral hemodynamics by dynamic susceptibility contrast magnetic resonance imaging after indirect bypass surgery for Moyamoya disease. World Neurosurg 2017;108:427–35 doi:10.1016/j.wneu.2017.09.001 pmid:28893695

    CrossRefPubMed